GDF15 and familial pancreatic carcinoma: In the training group, levels of miR-20a, miR-21, miR-25, miR-155, miR-196a, miR-210, MIC-1 and CA19-9 were significantly higher in the plasma of patients with pancreatic cancer compared with those of healthy controls (Figure 1, P< 0.001).